The 7th Jubilee seminar will examine the upcoming revolution in pharmacovigilance (PV) enabled by the latest technologies. What works, what does not, what regulators allow, and how does GxP validate the advanced language models for PV?
Join TransCelerate member Andrew Bate (Vice President, Head of Safety & Analytics, GSK) on 4 December for the session “Large Language Models & Generative AI-New 2023 Disruptors for PV Industry” (8:45-10:00 a.m. EST) and the 15:00-16:30 EST session “AI in Data Analysis & Signal Detection,” where he will be joined by fellow TransCelerate Intelligent Automation Opportunities in Pharmacovigilance team member Neal Grabowski (Head of Signal Management, Sanofi).